Maker of drug touted as coronavirus cure accuses China of gouging

Financial Times

24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy.

One of the world’s biggest makers of hydroxychloroquine has accused Chinese factories of price gouging it on important ingredients for an anti-malarial drug promoted by US president Donald Trump as a potential coronavirus cure.

India is the largest producer of hydroxychloroquine, a drug that Mr Trump has described as a “game changer” in the hunt for a COVID-19 treatment, even though experts within his own administration have warned that its efficacy is unproven and it is potentially dangerous. The country relies on raw materials from China to produce the finished drug.

Read Financial Times article

Michael Wonder

Posted by:

Michael Wonder